Free Trial

Silo Pharma (SILO) SEC Filings & 10K Form

Silo Pharma logo
$0.94 -0.03 (-3.09%)
(As of 11/20/2024 ET)

Recent Silo Pharma SEC Filings

DateFilerForm TypeView
11/15/2024
4:21 PM
Silo Pharma (Filer)
Form DEFR14A
11/13/2024
1:50 PM
RENAISSANCE TECHNOLOGIES LLC (Filed by)
Silo Pharma (Subject)
Form SCHEDULE 13G
09/18/2024
3:17 PM
Silo Pharma (Filer)
Form DEFA14A
09/18/2024
3:19 PM
Silo Pharma (Filer)
Form ARS
09/18/2024
3:15 PM
Silo Pharma (Filer)
Form DEF 14A
09/10/2024
5:46 AM
Silo Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/04/2024
2:01 PM
Silo Pharma (Filer)
Form 424B3
09/03/2024
11:15 PM
Silo Pharma (Filer)
Form EFFECT
08/21/2024
4:20 PM
Silo Pharma (Filer)
Form S-1
Registration statement under Securities Act of 1933  
08/02/2024
12:16 PM
Silo Pharma (Filer)
Form D
Notice of Exempt Offering of Securities 
07/30/2024
11:15 PM
Silo Pharma (Filer)
Form EFFECT
07/26/2024
3:17 PM
INTRACOASTAL CAPITAL, LLC (Filed by)
Silo Pharma (Subject)
Form SC 13G
07/25/2024
3:30 PM
Silo Pharma (Filer)
Form S-1/A
07/22/2024
4:00 PM
Silo Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/22/2024
5:06 AM
Silo Pharma (Filer)
Form 424B5
07/17/2024
3:45 PM
Silo Pharma (Filer)
Form S-1
Registration statement under Securities Act of 1933  
07/08/2024
3:15 PM
Silo Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/27/2024
3:23 PM
Silo Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/13/2024
4:08 PM
INTRACOASTAL CAPITAL, LLC (Filed by)
Silo Pharma (Subject)
Form SC 13G
06/13/2024
12:19 PM
Silo Pharma (Issuer)
Weisblum Eric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2024
3:52 PM
Silo Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/06/2024
5:07 AM
Silo Pharma (Filer)
Form 424B5
04/01/2024
5:15 PM
Silo Pharma (Issuer)
Weisblum Eric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/25/2024
4:23 PM
Silo Pharma (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/01/2024
12:15 PM
Silo Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/30/2024
11:15 PM
Silo Pharma (Filer)
Form EFFECT
01/25/2024
4:27 PM
Reda Joseph (Filed by)
Silo Pharma (Subject)
Form SC 13G/A
01/25/2024
4:29 PM
Silo Pharma (Filer)
Form S-3/A
01/11/2024
11:15 AM
Silo Pharma (Filer)
Form 8-K/A
01/09/2024
3:30 PM
Silo Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/20/2023
3:58 PM
Silo Pharma (Filer)
Form 8-K12B
12/18/2023
6:44 PM
Silo Pharma (Issuer)
Weisblum Eric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/07/2023
5:13 PM
Silo Pharma (Issuer)
Weisblum Eric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/30/2023
8:10 PM
Silo Pharma (Issuer)
Weisblum Eric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/27/2023
4:13 PM
Silo Pharma (Issuer)
Weisblum Eric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/20/2023
6:51 PM
Silo Pharma (Issuer)
Weisblum Eric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:SILO) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners